The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A comprehensive catalogue of somatic mutations from a human cancer genome
Open accessAbstract
All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic. The two cancer genome sequences presented in this issue demonstrate how next-generation sequencing technologies can inform us about mutational processes, repair pathways and gene networks associated with cancer development. First, the genome of a cell line derived from a bone marrow metastasis in a patient who had small-cell lung cancer. This cancer is typical of the type induced by smoking, and the sequence contains mutation signatures characteristic of some of the more than 60 carcinogens present in tobacco smoke. The second paper compares the whole genome sequence of a melanoma cell line to a lymphoblastoid cell line from the same individual. This, the first complete mutational analysis of a solid tumour, reveals a dominant mutational signature reflecting DNA damage due to exposure to ultraviolet light. Here, the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person are sequenced, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The data provide insight into the causes of tumour formation and the development of the cancer genome, with the dominant mutational signature reflecting DNA damage due to ultraviolet light exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanoma somatic mutations consist almost entirely of C → T transitions, 28% of which are TCC → T mutations (19,31).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,029
Velvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Genome sequencing in microfabricated high-density picolitre reactors
Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J., Braverman, M. S., Chen, Y.-J., Chen, Z., et al. (2005) · Nature · doi:10.1038/nature03959 · Cited by 7,693
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationAccurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
Self-citationStratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationA census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Self-citation
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,001
Lin, X., Tang, W., Ahmad, S., Lü, J., Colby, C. C., Zhu, J., & Yu, Q. (2012) · Hearing Research · doi:10.1016/j.heares.2012.01.004 · Cited by 115
Immunology of cancer stem cells in solid tumours. A review
Maccalli, C., Volonté, A., Cimminiello, C., & Parmiani, G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.014 · Cited by 110
Cancer in Light of Experimental Evolution
Sprouffske, K., Merlo, L. M. F., Gerrish, P. J., Maley, C. C., & Sniegowski, P. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.065 · Cited by 110
Smid, M., Rodríguez-González, F. G., Sieuwerts, A. M., Salgado, R., der Smissen, W. J. C. P., van der Vlugt‐Daane, M., van Galen, A., Nik‐Zainal, S., Staaf, J., Brinkman, A. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12910 · Cited by 105
Self-citationThe Role of Altered Nucleotide Excision Repair and UVB-Induced DNA Damage in Melanomagenesis
Budden, T., & Bowden, N. A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011132 · Cited by 113
ZHENG, C. L., Wang, N. J., Chung, J., Moslehi, H., Sanborn, Z., Hur, J., Collisson, E. A., Vemula, S. S., Naujokas, A., Chiotti, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.031 · Cited by 112
Turakhia, Y., Bejerano, G., & Dally, W. J. (2018) · International Conference on Architectural Support for Programming Languages and Operating Systems (ASPLOS) · doi:10.1145/3173162.3173193 · Cited by 116
Deciphering UV‐induced DNA Damage Responses to Prevent and Treat Skin Cancer
Lee, J. W., Ratnakumar, K., Hung, K., Rokunohe, D., & Kawasumi, M. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13245 · Cited by 121
Characterizing complex structural variation in germline and somatic genomes
Quinlan, A. R., & Hall, I. M. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.10.002 · Cited by 108
Ivakhno, S., Royce, T., Cox, A. J., Evers, D. J., Cheetham, R. K., & Tavaré, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq587 · Cited by 105
Self-citationEMu: probabilistic inference of mutational processes and their localization in the cancer genome
Fischer, A., Illingworth, C. J. R., Campbell, P. J., & Mustonen, V. (2013) · Genome biology · doi:10.1186/gb-2013-14-4-r39 · Cited by 105
Self-citationTargeting Oncogenic Drivers and the Immune System in Melanoma
McArthur, G. A., & Ribas, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5568 · Cited by 108
Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective
Teng, Y., Yu, Y., Li, S., Huang, Y., Xu, D., Tao, X., & Fan, Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.666528 · Cited by 121
Beckman, R. A., Schemmann, G. S., & Yeang, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203559109 · Cited by 106
Synthetic lethal approaches to breast cancer therapy
Rehman, F. L., Lord, C. J., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.172 · Cited by 104
APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells
Shinohara, M., Io, K., Shindo, K., Matsui, M., Sakamoto, T., Tada, K., Kobayashi, M., Kadowaki, N., & Takaori‐Kondo, A. (2012) · Scientific Reports · doi:10.1038/srep00806 · Cited by 103
Somatic Genome Variations in Health and Disease
Iourov, I. Y., Vorsanova, S. G., & Yurov, Y. B. (2010) · Current Genomics · doi:10.2174/138920210793176065 · Cited by 102
PON-P: Integrated predictor for pathogenicity of missense variants
Olatubosun, A., Väliaho, J., Härkönen, J., Thusberg, J., & Vihinen, M. (2012) · Human Mutation · doi:10.1002/humu.22102 · Cited by 103
Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis
Sabour, L., Takanlou, M. S., & Ghorbian, . (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0124-z · Cited by 108
Cancer genome-sequencing study design
Mwenifumbo, J. C., & Marra, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3445 · Cited by 104
Taming the dragon: genomic biomarkers to individualize the treatment of cancer
Majewski, I. J., & Bernards, R. (2011) · Nature Medicine · doi:10.1038/nm.2311 · Cited by 101
L1 retrotransposons, cancer stem cells and oncogenesis
Carreira, P. E., Richardson, S. R., & Faulkner, G. J. (2013) · FEBS Journal · doi:10.1111/febs.12601 · Cited by 100
Aberrant phase separation and cancer
Taniue, K., & Akimitsu, N. (2021) · FEBS Journal · doi:10.1111/febs.15765 · Cited by 101
Aganezov, S. S., Goodwin, S., Sherman, R. M., Sedlazeck, F. J., Arun, G., Bhatia, S., Lee, I., Kirsche, M., Wappel, R. L., Kramer, M., et al. (2020) · Genome Research · doi:10.1101/gr.260497.119 · Cited by 104
Valente, V., Serafim, R. B., de Oliveira, L. C., Adorni, F. S., Torrieri, R., Tirapelli, D. P. D. C., Espreáfico, E. M., Oba‐Shinjo, S. M., Marie, S. K. N., Paçó‐Larson, M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062200 · Cited by 100
Blundell, J. R., & Levy, S. F. (2014) · Genomics · doi:10.1016/j.ygeno.2014.09.005 · Cited by 98
Vergani, E., Vallacchi, V., Frigerio, S., Deho, P., Mondellini, P., Perego, P., Cassinelli, G., Lanzi, C., Testi, M., Rivoltini, L., et al. (2011) · Neoplasia · doi:10.1593/neo.111102 · Cited by 99
Characterising chromosome rearrangements: recent technical advances in molecular cytogenetics
Scouarnec, S. L., & Gribble, S. M. (2011) · Heredity · doi:10.1038/hdy.2011.100 · Cited by 102
Zmajkovicova, K., Jesenberger, V., Catalanotti, F., Baumgärtner, C., Reyes, G. X., & Baccarini, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.037 · Cited by 99
Do mutator mutations fuel tumorigenesis?
Fox, E. J., Prindle, M. J., & Loeb, L. A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9426-8 · Cited by 109
Next Generation DNA Sequencing and the Future of Genomic Medicine
Anderson, M. W., & Schrijver, I. (2010) · Genes · doi:10.3390/genes1010038 · Cited by 105
TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Griewank, K., Murali, R., Schilling, B., Schimming, T. T., Möller, I., Moll, I., Schwamborn, M., Sucker, A., Zimmer, L., Schadendorf, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080354 · Cited by 97
A comparative analysis of algorithms for somatic SNV detection in cancer
Roberts, N. D., Kortschak, R. D., Parker, W. T., SCHREIBER, A. W., Branford, S., Scott, H. S., Glonek, G., & Adelson, D. L. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt375 · Cited by 98
Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma
Shull, A. Y., Latham-Schwark, A., Ramasamy, P., Leskoske, K. L., Oroian, D., Birtwistle, M. R., & Buckhaults, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043369 · Cited by 105
Mechanisms involved in lung cancer development in COPD
Caramori, G., Casolari, P., Cavallesco, N. G., Giuffré, S., Adcock, I. M., & Papi, A. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.022 · Cited by 100
Unraveling the Genetics of Cancer: Genome Sequencing and Beyond
Wong, K. M., Hudson, T. J., & McPherson, J. D. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141532 · Cited by 96
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
Rozeman, E. A., Dekker, T. J. A., Haanen, J. B. A. G., & Blank, C. U. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0325-6 · Cited by 99
Lim, H. W., James, W. D., Rigel, D. S., Maloney, M. E., SPENCER, J. M., & Bhushan, R. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.03.007 · Cited by 97
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes
McBride, D. J., Etemadmoghadam, D., Cooke, S. L., Alsop, K., George, J., Butler, A. P., Cho, J., Galappaththige, D., Greenman, C., Howarth, K., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4042 · Cited by 97
Self-citationUnique mutation portraits and frequent COL2A1 gene alteration in chondrosarcomaPreprint
Totoki, Y., Yoshida, A., Hosoda, F., Nakamura, H. K., Hama, N., Ogura, K., Yoshida, A., Fujiwara, T., Arai, Y., Toguchida, J., et al. (2014) · Genome Research · doi:10.1101/gr.160598.113 · Cited by 97
Xia, J., Jia, P., Hutchinson, K. E., Dahlman, K. B., Johnson, D., Sosman, J., Pao, W., & Zhao, Z. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0804 · Cited by 94
Yost, S. E., Smith, E. N., Schwab, R. B., Bao, L., Jung, H., Wang, X., Voest, E. E., Pierce, J. P., Messer, K. S., Parker, B. A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks299 · Cited by 95
Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma
Mohr, P., Birgersson, U., Berking, C., Henderson, C., Trefzer, U., Kemény, L. V., Sunderkötter, C. H., Dirschka, T., Motley, R., Frohm‐Nilsson, M., et al. (2013) · Skin Research and Technology · doi:10.1111/srt.12008 · Cited by 98
Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer
Jager, M., Blokzijl, F., Kuijk, E., Bertl, J., Vougioukalaki, M., Janssen, R., Besselink, N., Boymans, S., de Ligt, J., Pedersen, J. S., et al. (2019) · Genome Research · doi:10.1101/gr.246223.118 · Cited by 98
Liu, B., Morrison, C. D., Johnson, C. S., Trump, D. L., Qin, M., Conroy, J., Wang, J., & Liu, S. (2013) · Oncotarget · doi:10.18632/oncotarget.1537 · Cited by 96
The specificity of UVA-induced DNA damage in human melanocytes
Mouret, S., Forestier, A., & Douki, T. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05185g · Cited by 94
UVA photosensitization of thiopurines and skin cancer in organ transplant recipients
Attard, N. R., & Karran, P. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05194f · Cited by 94
Cancer systems biology of TCGA SKCM: Efficient detection of genomic drivers in melanoma
Guan, J., Gupta, R., & Filipp, F. V. (2015) · Scientific Reports · doi:10.1038/srep07857 · Cited by 99
Personalized medicine—a modern approach for the diagnosis and management of hypertension
Savoia, C., Volpe, M., Grassi, G., Borghi, C., Rosei, E. A., & Touyz, R. M. (2017) · Clinical Science · doi:10.1042/cs20160407 · Cited by 97
GenAx: A Genome Sequencing Accelerator
Fujiki, D., Subramaniyan, A. K., Zhang, T., Zeng, Y., Das, R., Blaauw, D. T., & Narayanasamy, S. (2018) · Proceedings - International Symposium on Computer Architecture/Proceedings · doi:10.1109/isca.2018.00017 · Cited by 94
Cohen, S., Lewis, C. A., Mooney, R. A., Kohanski, M. A., Collins, J. J., Landick, R. C., & Walker, G. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005203107 · Cited by 95
Small genomic insertions form enhancers that misregulate oncogenes
Abraham, B. J., Hnisz, D., Weintraub, A. S., Kwiatkowski, N. P., Li, C. H., Li, Z., Weichert‐Leahey, N., Rahman, S., Liu, Y., Etchin, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14385 · Cited by 96
Proctor, I., Stoeber, K., & Williams, G. H. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03592.x · Cited by 93
Cytotoxic CD8+ Lymphocytes in the Tumor Microenvironment
Iwahori, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_4 · Cited by 102
UVA1 is skin deep: molecular and clinical implications
Tewari, A., Grage, M. M.-L., Harrison, G. I., Sarkany, R., & Young, A. R. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25323b · Cited by 97
Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
Pritchard, A. L., & Hayward, N. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0383 · Cited by 97
Hazen, J. L., Faust, G. G., Rodriguez, A. R., Ferguson, W. C., Shumilina, S., Clark, R. A., Boland, M. J., Martin, G., Chubukov, P., Tsunemoto, R. K., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.004 · Cited by 95
Next-generation DNA damage sequencing
Mingard, C., Wu, J., McKeague, M., & Sturla, S. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00647e · Cited by 92
Human cancer databases (Review)
Pavlopoulou, A., Spandidos, D. A., & Michalopoulos, I. (2014) · Oncology Reports · doi:10.3892/or.2014.3579 · Cited by 97
Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology
Lolkema, M. P., Hooijdonk, C. G. G., Bredenoord, A. L., Kapitein, P., Roach, N., Cuppen, E. P. J. G., Knoers, N. V. A. M., & Voest, E. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2789 · Cited by 90
SeqWare Query Engine: storing and searching sequence data in the cloud
O’Connor, B. D., Merriman, B., & Nelson, S. F. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s12-s2 · Cited by 92
Ghoreyshi, N., Heidari, R., Farhadi, A., Chamanara, M., Farahani, N., Vahidi, M., & Behroozi, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-01816-9 · Cited by 91
Personal genomes in progress: from the Human Genome Project to the Personal Genome Project
Lunshof, J. E., Bobe, J. R., Aach, J., Angrist, M. H., Thakuria, J. V., Vorhaus, D. B., Hoehe, M. R., & Church, G. M. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/jlunshof · Cited by 90
Lee, J., Lee, A., Lee, J., Park, J., Kwon, Y., Park, S., Chun, H., Ju, Y., & Hong, D. (2018) · Nucleic Acids Res. · doi:10.1093/nar/gky406 · Cited by 84
The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine
Öztürk, K., Dow, M. T., Carlin, D. E., Bejar, R. L., & Carter, H. K. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.016 · Cited by 90
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed
Brennan, P., & Smith, G. D. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab204 · Cited by 92
Precision therapy for lymphoma—current state and future directions
Intlekofer, A. M., & Younes, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.137 · Cited by 91
Zhang, X. C., Xu, C., Mitchell, R. M., Zhang, B., Zhao, D., Li, Y., Huang, X. H., Fan, W., Wang, H., Lerma, L. A., et al. (2013) · Neoplasia · doi:10.1593/neo.131400 · Cited by 89
Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy
Chatterjee, S., & Sil, P. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.027 · Cited by 91
Gorini, F., Scala, G., Cooke, M. S., Majello, B., & Amente, S. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.103027 · Cited by 96
Rapid learning for precision oncology
Shrager, J., & Tenenbaum, J. M. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.244 · Cited by 88
Whole-Genome Sequencing in CancerPreprint
Stutheit-Zhao, E. Y., Jones, M. R., & Jones, S. J. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034579 · Cited by 93
The genetics of melanoma: recent advances
Hill, V. K., Gartner, J. J., Samuels, Y., & Goldstein, A. M. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153429 · Cited by 86
Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks
Roukos, D. H. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.81 · Cited by 86
Passenger Hotspot Mutations in Cancer
Hess, J. M., Bernards, A., Kim, J., Miller, M. L., Taylor-Weiner, A. N., Haradhvala, N. J., Lawrence, M. S., & Getz, G. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.002 · Cited by 89
Lavigne, M. D., Konstantopoulos, D., Ntakou‐Zamplara, K. Z., Liakos, A., & Fousteri, M. I. (2017) · Nature Communications · doi:10.1038/s41467-017-02145-4 · Cited by 88
Oncogenes and tumor suppressor genes: comparative genomics and network perspectives
Zhu, K., Liu, Q., Zhou, Y., Tao, C., Zhao, Z., Sun, J., & Xu, H. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s8 · Cited by 89
Next-Generation, Genome Sequencing-Based Biomarkers: Concerns and Challenges for Medical Practice
Roukos, D. H. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.70 · Cited by 88
Wagstaff, W., Mwamba, R. N., Grullon, K., Armstrong, M. L., Zhao, P., Hendren-Santiago, B. K., Qin, K. H., Li, A. J., Hu, D. A., Youssef, A., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.004 · Cited by 94
Zhao, H., Thienpont, B., Yesilyurt, B. T., Moisse, M., Reumers, J., Coenegrachts, L., Sagaert, X., Schrauwen, S., Smeets, D., Matthijs, G., et al. (2014) · eLife · doi:10.7554/elife.02725 · Cited by 88
Mimaki, S., Totsuka, Y., Suzuki, Y., Nakai, C., Goto, M., Kojima, M., Arakawa, H., Takemura, S., Tanaka, S., Marubashi, S., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw066 · Cited by 85
Clonal Architectures and Driver Mutations in Metastatic Melanomas
Ding, L., Kim, M., Kanchi, K., Dees, N. D., Lu, C., Griffith, M., Fenstermacher, D., Sung, H., Miller, C. A., Goetz, B. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111153 · Cited by 85
When Genome Maintenance Goes Badly Awry
Kass, E. M., Moynahan, M. E., & Jasin, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.021 · Cited by 84
CONSERTING: integrating copy-number analysis with structural-variation detection
Chen, X. '., Gupta, P., Wang, J., Nakitandwe, J., Roberts, K. G., Dalton, J., Parker, M. D., PATEL, S. N., Holmfeldt, L., Payne, D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3394 · Cited by 81
Harnessing the immune response to treat cancer
Steer, H. J., Lake, R., Nowak, A. K., & Robinson, B. W. S. (2010) · Oncogene · doi:10.1038/onc.2010.437 · Cited by 86
Mutations and epimutations in the origin of cancer
Peltomäki, P. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.12.001 · Cited by 88
Metastatic melanoma treatment: Combining old and new therapies
Davey, R. J., van der Westhuizen, A., & Bowden, N. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.11.011 · Cited by 90
Zammataro, L. A., Lopez, S., Bellone, S., Pettinella, F., Bonazzoli, E., Perrone, E., Zhao, S., Menderes, G., Altwerger, G. H., Han, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911385116 · Cited by 84
Franco, I., Helgadottir, H. T., Moggio, A., Larsson, M., Vrtačnik, P., Johansson, A., Norgren, N., Lundin, P., Mas-Ponte, D., Nordström, J., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1892-z · Cited by 83
A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expression
Liu, Y., Gu, Q., Hou, J. P., Han, J., & Ma, J. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-37 · Cited by 84
Scales and mechanisms of somatic mutation rate variation across the human genome
Supek, F., & Lehner, B. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102647 · Cited by 76
Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy
Ma, Y., Xia, R., Ma, X., Judson‐Torres, R. L., & Zeng, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.702287 · Cited by 88
Micro RNA ‐142 is mutated in about 20% of diffuse large B ‐cell lymphoma
Klangbud, W. K., Lenze, D., Alles, J., Motsch, N., Barth, S., Döll, C., Imig, J., Hummel, M., Tinguely, M., Trivedi, P., et al. (2012) · Cancer Medicine · doi:10.1002/cam4.29 · Cited by 82
Christoforides, A., Carpten, J. D., Weiss, G. J., Demeure, M. J., Hoff, D. D. V., & Craig, D. W. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-302 · Cited by 81
High-affinity interaction of the K-Ras4B hypervariable region with the RAS active site
Chavan, T. S., Jang, H., Khavrutskii, L., Abraham, S. J., Banerjee, A., Freed, B. C., Johannessen, L., Tarasov, S. G., Gaponenko, V., Nussinov, R., et al. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.09.034 · Cited by 79
UVA Radiation, DNA Damage, and Melanoma
Jin, S., Padron, F., & Pfeifer, G. P. (2022) · ACS Omega · doi:10.1021/acsomega.2c04424 · Cited by 87
Copy Number Gains in 11q13 and 8q34 Are Highly Linked to Prognosis in Cutaneous Malignant Melanoma
Gerami, P., Jewell, S. S., Pouryazdanparast, P., Wayne, J. D., Haghighat, Z., BUSAM, K. J., RADEMAKER, A. W., & Morrison, L. E. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.01.011 · Cited by 81
Somatic Point Mutation Calling in Low Cellularity Tumors
Kassahn, K. S., Holmes, O., Nones, K., Patch, A., Miller, D. K., Christ, A. N., Harliwong, I., Bruxner, T. J. C., Xu, Q., Anderson, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074380 · Cited by 81
Sethi, M., Lehmann, A. R., Fawcett, H., Stefanini, M., Jaspers, N. G. J., Mullard, K. S., Turner, S., Robson, A., McGibbon, D., Sarkany, R., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12523 · Cited by 81
A somatic reference standard for cancer genome sequencing
Craig, D. W., Nasser, S., Corbett, R., Chan, S. K., Murray, L., Legendre, C., Tembe, W., Adkins, J. R., Kim, N., Wong, S., et al. (2016) · Scientific Reports · doi:10.1038/srep24607 · Cited by 83
Self-citation
Metadata
- Authors
- Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., Ye, K., Alipaz, J., Bauer, M. J., Beare, D., Butler, A., Carter, R. J., Chen, L., Cox, A. J., Edkins, S., Kokko-Gonzales, P. I., Gormley, N. A., Grocock, R. J., Haudenschild, C. D., Hims, M. M., James, T., Jia, M., Kingsbury, Z., Leroy, C., Marshall, J., Menzies, A., Mudie, L. J., Ning, Z., Royce, T., Schulz-Trieglaff, O. B., Spiridou, A., Stebbings, L. A., Szajkowski, L., Teague, J., Williamson, D., Chin, L., Ross, M. T., Campbell, P. J., Bentley, D. R., Futreal, P. A., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Illumina (United Kingdom) (GB)
- Leiden University Medical Center (NL)
- Illumina (United States) (US)
- Dana-Farber Cancer Institute (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Futreal, P. Andrew
- Stratton, Michael R.
- ORCID
- Pleasance, Erin D.
- McBride, David J.
- Humphray, Sean J.
- Greenman, Chris D.
- Varela, Ignacio
- Lin, Meng-Lay
- Ye, Kai
- Bauer, Markus J.
- Chen, Lina
- Edkins, Sarah
- James, Terena
- Jia, Mingming
- Marshall, John
- Menzies, Andrew
- Ning, Zemin
- Spiridou, Anastassia
- Teague, Jon
- Ross, Mark T.
- Campbell, Peter J.
- Futreal, P. Andrew
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2009-12-16
- Volume
- 463
- Issue
- 7278
- Pages
- 191-196
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3145108
- OpenAlex
- W2150677022
- Cited by
- 1,696
- References
- 43
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 43 · 2023: 49 · 2022: 50 · 2021: 83 · 2020: 76 · 2019: 87 · 2018: 69 · 2017: 94 · 2016: 121 · 2015: 116 · 2014: 144 · 2013: 166 · 2012: 189
- FWCI
- 58.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust (077012/Z/05/Z, 077012, 088340, 093867)
- Kay Kendall Leukaemia Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- somatic mutations, mutational signatures, melanoma, lymphoblastoid cell lines, DNA repair, small cell lung cancer, tobacco smoke carcinogens, driver mutations, passenger mutations, cancer genome evolution
- MeSH terms
- Adult, DNA Damage, DNA Mutational Analysis, DNA Repair, Humans, Male, Melanoma, Mutation, Neoplasms, Ultraviolet Rays, Genome, Human, Mutagenesis, Insertional, Sequence Deletion, Gene Dosage, Loss of Heterozygosity, Polymorphism, Single Nucleotide, MicroRNAs, Cell Line, Tumor, Genes, Neoplasm, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
